Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

On Friday, iTeos TherapeuticsITOS got a positive adjustment to its Relative Strength (RS) Rating, from 70 to 76. Please watch the video at Investors.com - How To Trade Options: Choosing The Right ...

Kymera Therapeutics posted 0% EPS growth in its most recent report, while sales growth came in at 115%. The company earns the No. 109 rank among its peers in the Medical-Biomed/Bi ...

This was the stock's fourth consecutive day of gains.